Previous studies demonstrated that CCL5, by binding to the CCR5 receptor and activating associated pathways, impacts learning and memory, brain development, neuroinflammation, and neurodegenerative diseases, such as Alzheimer’s disease (AD) [48]. This evidence concerns the gene CCL5 and Alzheimer disease.